Risk factor
Very high price volatility
Profitability factor
Very favourable analyst view
About
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions comprise bone graft...
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITDA, u
Target Price
The average target price of BVS is 15 and suggests 78% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase
Buy
Sell